3Yamaguchi A, Skolarikos A, Buchholz NP, et al. Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study. J Endourol, 2011, 25: 933-939. 被引量：1
5Wagenlehner FM, Weidner W, Naber KG. Optimal management of urosepsis from the urological perspective. Int J Antimicrob Agents, 2007, 30 : 390-397. 被引量：1
6Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med, 2001, 164: 396-402. 被引量：1
7Labate G, Modi P, Timoney A, et al. The percutaneous nephrolithotomy global study : classification of complications. J Endourol, 2011, 25 : 1275-1280. 被引量：1
